New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

dc.contributor.authorTayná Marques
dc.contributor.authorColin Forsyth
dc.contributor.authorFabiana Barreira
dc.contributor.authorCarola Lombas
dc.contributor.authorB Oliveira
dc.contributor.authorMónica Laserna
dc.contributor.authorIsrael Molina
dc.contributor.authorMaría del Carmen Bangher
dc.contributor.authorRosa Martí Fernández
dc.contributor.authorSusana Lloveras
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:45:41Z
dc.date.available2026-03-22T19:45:41Z
dc.date.issued2025
dc.description.abstractNCT04897516.
dc.identifier.doi10.1136/bmjopen-2024-098079
dc.identifier.urihttps://doi.org/10.1136/bmjopen-2024-098079
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/77960
dc.language.isoen
dc.publisherBMJ
dc.relation.ispartofBMJ Open
dc.sourceElea (Argentina)
dc.subjectMedicine
dc.subjectBenznidazole
dc.subjectInternal medicine
dc.subjectIndeterminate
dc.subjectChagas disease
dc.subjectDisease
dc.subjectEpidemiology
dc.subjectOncology
dc.subjectQuality of Life Research
dc.subjectClinical trial
dc.titleNew regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial
dc.typearticle

Files